PPIDT00099
Drug Information
| Name | Nafarelin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB00666 |
| Type | small molecule |
| Indication | For treatment of central precocious puberty (true precocious puberty, GnRH-dependent precocious precocity, complete isosexual precocity) in children of both sexes and for the treatment of endometriosis. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Aerosol, metered | Nasal |
200 mcg / act
|
| Spray, metered | Nasal |
2 mg/1mL
|
| Liquid | Nasal |
2 mg / mL
|